Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

370 ARTÍCULOS , VIENDO DEL 271 AL 285

Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study

Sarycheva T, Lavikainen P, Taipale H, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen AM.

J Am Heart Assoc. 2018 Sep 18;7(18):e009742. doi: 10.1161/JAHA.118.009742.

The Mitochondrion: A Potential Therapeutic Target for Alzheimer's Disease

Lu MH, Zhao XY, Yao PP, Xu DE, Ma QH.

Neurosci Bull. 2018 Dec;34(6):1127-1130. doi: 10.1007/s12264-018-0310-y. Epub 2018 Nov 12.

Identification of the optimal cognitive drugs among Alzheimer's disease: a Bayesian meta-analytic review

Liang J, Li J, Jia R, Wang Y, Wu R, Zhang H, Hang L, Xu Y.

Clin Interv Aging. 2018 Oct 18;13:2061-2073. doi: 10.2147/CIA.S184968. eCollection 2018.

Chromones: privileged scaffolds for the production of multi-target-directed-ligand agents for the treatment of Alzheimer's disease

Silva CFM, Pinto DCGA, Silva AMS.

Expert Opin Drug Discov. 2018 Dec;13(12):1141-1151. doi: 10.1080/17460441.2018.1543267. Epub 2018 Nov 15.

Geroneuroprotectors: Effective Geroprotectors for the Brain

Schubert D, Currais A, Goldberg J, Finley K, Petrascheck M, Maher P.

Trends Pharmacol Sci. 2018 Dec;39(12):1004-1007. doi: 10.1016/j.tips.2018.09.008. Epub 2018 Nov 13.

Efficacy, Acceptability, and Safety of Intravenous Immunoglobulin Administration for Mild-To-Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis

Okuya M, Matsunaga S, Ikuta T, Kishi T, Iwata N.

J Alzheimers Dis. 2018;66(4):1379-1387. doi: 10.3233/JAD-180888.

Anti-amyloid Therapy of Alzheimer's Disease: Current State and Prospects

Kozin SA, Barykin EP, Mitkevich VA, Makarov AA.

Biochemistry (Mosc). 2018 Sep;83(9):1057-1067. doi: 10.1134/S0006297918090079.

Where are we at with model-based economic evaluations of interventions for dementia? a systematic review and quality assessment

Nguyen KH, Comans TA, Green C.

Int Psychogeriatr. 2018 Nov;30(11):1593-1605. doi: 10.1017/S1041610218001291.

Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1

Gomes BAQ, Silva JPB, Romeiro CFR, Dos Santos SM, Rodrigues CA, Gonçalves PR, Sakai JT, Mendes PFS, Varela ELP, Monteiro MC.

Oxid Med Cell Longev. 2018 Oct 30;2018:8152373. doi: 10.1155/2018/8152373. eCollection 2018.

Will Europe be ready for the treatment of Alzheimer's disease?

The Lancet Neurology.

Lancet Neurol. 2018 Dec;17(12):1025. doi: 10.1016/S1474-4422(18)30409-5. Epub 2018 Nov 13.

Effects of Light Treatment on Sleep, Cognition, Mood, and Behavior in Alzheimer's Disease: A Systematic Review

Mitolo M, Tonon C, La Morgia C, Testa C, Carelli V, Lodi R.

Dement Geriatr Cogn Disord. 2018;46(5-6):371-384. doi: 10.1159/000494921. Epub 2018 Dec 11.

Status of Noninvasive Brain Stimulation in the Therapy of Alzheimer's Disease

Lin YC, Wang YP.

Chin Med J (Engl). 2018 Dec 20;131(24):2899-2903. doi: 10.4103/0366-6999.247217.

Advances in developing novel therapeutic strategies for Alzheimer's disease

Cao J, Hou J, Ping J, Cai D.

Mol Neurodegener. 2018 Dec 12;13(1):64. doi: 10.1186/s13024-018-0299-8.

Molecular and Functional Interaction of the Myokine Irisin with Physical Exercise and Alzheimer's Disease

Jin Y, Sumsuzzman DM, Choi J, Kang H, Lee SR, Hong Y.

Molecules. 2018 Dec 7;23(12):3229. doi: 10.3390/molecules23123229.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias